Jan Medical, Inc.
12
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
25.0%
3 terminated/withdrawn out of 12 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Pilot Study of Acute Stroke Using the Brainpulse™
Role: lead
Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke
Role: lead
Un-blinded Data Collection Study of Concussion Using the BrainPulse(TM)
Role: lead
Concussion Testing: A Novel Non-invasive Concussion Detection Device
Role: lead
Control Study of Nautilus BrainPulse for the Detection of Concussion
Role: lead
Comparing the Nautilus NeuroWaveTM to TCD or DSA for the Detection of Vasospasm
Role: lead
A Study to Assess the Effectiveness of the Nautilus BrainPulse™ as an Aid in the Diagnosis of Concussion
Role: lead
Non-blinded Data Collection Study of Concussion Using the BrainPulse(TM)
Role: lead
Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm
Role: lead
Evaluation of a Non-invasive Brain Compliance Measurement Device
Role: collaborator
Dementia Signal Development Study of Nautilus NeuroWave TM for the Detection of Dementia
Role: lead
Unblinded Data Collection Study of Concussion Using BrainPulse
Role: lead
All 12 trials loaded